Foster Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.56M Buy
2,136
+269
+14% +$275K 0.07% 78
2026
Q1
$1.72M Sell
1,867
-23
-1% -$23.3K 0.05% 87
2025
Q4
$2.03M Buy
1,890
+157
+9% +$150K 0.06% 78
2025
Q3
$1.32M Buy
1,733
+8
+0.5% +$5.95K 0.04% 93
2025
Q2
$1.34M Sell
1,725
-123
-7% -$95.6K 0.05% 87
2025
Q1
$1.53M Buy
1,848
+253
+16% +$211K 0.06% 75
2024
Q4
$1.23M Buy
1,595
+39
+3% +$32.3K 0.05% 77
2024
Q3
$1.38M Sell
1,556
-798
-34% -$717K 0.05% 76
2024
Q2
$2.13M Buy
2,354
+713
+43% +$570K 0.08% 62
2024
Q1
$1.28M Buy
1,641
+51
+3% +$36.3K 0.06% 77
2023
Q4
$854K Hold
1,590
0.05% 80
2023
Q3
$854K Buy
1,590
+141
+10% +$72.7K 0.05% 80
2023
Q2
$680K Buy
1,449
+294
+25% +$123K 0.04% 92
2023
Q1
$397K Sell
1,155
-33
-3% -$11.1K 0.03% 116
2022
Q4
$435K Buy
1,188
+155
+15% +$55K 0.03% 104
2022
Q3
$334K Buy
1,033
+102
+11% +$32.3K 0.03% 105
2022
Q2
$302K Buy
931
+113
+14% +$33.9K 0.02% 115
2022
Q1
$234K Sell
818
-1
-0.1% -$257 0.02% 125
2021
Q4
$226K Buy
+819
New +$208K 0.02% 129

Other funds holding LLY

Foster Group's LLY Position: Q2 2026 in Review

Foster Group increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $275K and bringing the position to 2,136 shares worth $2.56M. The position accounts for 0.07% of the portfolio, ranked #78.

Foster Group first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 2,061 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Foster Group held 2,136 shares of Eli Lilly worth $2.56M as of Q2 2026.
  • Foster Group bought 269 Eli Lilly shares in Q2 2026, an estimated $275K.
  • Eli Lilly made up 0.07% of Foster Group's portfolio in Q2 2026, its #78 holding.
  • Foster Group first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 2,061 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.